Fri.May 17, 2024

article thumbnail

Slideshow: The 5 Types of Asthma and Their Common Triggers

Drug Topics

While many people may be unaware of the different types of asthma, there are 5 ways individuals can experience the condition, with common triggers that heighten symptoms.

247
247
article thumbnail

Pharmacy Influencers Share How to Balance Passions and Career

Pharmacy Times

Three influencers from around the world showcase the passions they pursue outside the pharmacy industry.

180
180
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Approves Tarlatamab-dlle for Extensive-Stage Small Cell Lung Cancer

Drug Topics

Amgen’s Tarlatamab-dlle (Imdelltra) is the first and only approved DLL3-targeting bispecific T-cell engager therapy for the aggressive form of lung cancer.

FDA 200
article thumbnail

This Skin Cancer Awareness Month, Remind Patients of the Prevention Basics

Pharmacy Times

As summer approaches, remind patients to go back to basics with sunscreen and self-examinations.

149
149
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Data integrity watchdogs call for stronger safeguards in scientific journals

STAT

SAN FRANCISCO — According to Elisabeth Bik, a scientific watchdog who has discovered thousands of errors in scientific papers, the problem of fraud, errors, or data mishandling in the scientific literature seems to be getting worse. In the last couple of years, Bik’s been seeing an influx of AI-generated papers in the scientific record that are “nonsensical and clearly low quality.

143
143
article thumbnail

Report: The generative AI roadmap, its hurdles and strategies to mitigate

Fierce Healthcare

The panel that worked on the report was made up of Big Tech players like Amazon, Google and Microsoft, as well as leaders such as Harvard Medical School, the Leapfrog Group and Kaiser Permanente.

More Trending

article thumbnail

SDOH Framework Highlights Role of Health System Specialty Pharmacists

Pharmacy Times

Future potential directions include measuring the impact of clinical pharmacist interventions on referral utility, disease-specific clinical outcomes, patient satisfaction, medication adherence, and absenteeism.

132
132
article thumbnail

STAT+: ChatGPT for genomes: introducing a CRISPR-designing generative AI

STAT

In 2018, during her chemistry Nobel Prize lecture, Frances Arnold noted that scientists had arrived at a point where they could read, write, and edit any sequence of DNA. But composing whole genes or even whole genomes from scratch — that was something only evolution could do. A few years later, not long after helping to launch the Arc Institute, a nonprofit research center in the Bay Area, molecular engineer Patrick Hsu wondered if it was possible to imitate the forces of evolution

138
138
article thumbnail

Mental health inequities will cost U.S. $478B in 'unnecessary' expenses in 2024

Fierce Healthcare

Inequities in mental health across the U.S. | ED overutilization, exacerbated comorbidities and lost productivity will drive trillions in "avoidable and unnecessary expenses" should inequities in mental health access and outcomes remain unchecked.

128
128
article thumbnail

Opinion: Hurricane season is approaching fast. We need to talk about health care resilience

STAT

Extreme weather fueled by accelerating climate change puts patients, providers, and health care facilities at severe risk, jeopardizing lives. Unpredictable shifts in weather patterns are creating new regional extremes , and communities have to adjust to survive. During climate crises, health care providers and facilities must be ready to quickly adapt to shifting needs.

Hospitals 127
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Amgen's 'watershed' lung cancer drug nabs FDA nod in deadly, tough-to-treat form of the disease

Fierce Pharma

Seven months after Amgen’s chief medical officer referred to trial | Seven months after Amgen’s chief medical officer referred to trial results for the company's investigational lung cancer immunotherapy as a “watershed moment,” the FDA has signed off on Imdelltra (tarlatamab) to treat patients with extensive-stage small-cell lung cancer (ES-SCLC).

FDA 126
article thumbnail

STAT+: Wearable devices generate powerful data but it’s not useful to doctors, yet

STAT

Just because the Food and Drug Administration has given the Apple Watch and other wearable devices the OK to market the health benefits of their tracking and algorithms doesn’t mean that the data they generate are useful for either patients or their doctors, experts said Thursday at the STAT Breakthrough Summit West in San Francisco. “Yesterday, I saw a patient with type 2 diabetes who has a continuous glucose monitor, and so she’s been tracking her blood sugar every five mi

article thumbnail

The FDA Grants Accelerated Approval to Tarlatamab-dlle in Small Cell Lung Cancer

Pharmacy Times

Tarlatamab is a first-in-class immunotherapy that binds to DLL3 tumor cells and CD3 T-cells, to kill DLL3-expressing SCLC.

FDA 123
article thumbnail

Black women founders offer health tech solutions to combat Black maternal mortality

STAT

When Black people receive maternal care, they are often not treated the same as white people. In 2016, when Simmone Taitt had her first pregnancy loss, she was very well insured, had a high-paying job as a tech executive, and had access to one of the top OB-GYNs in New York City. Yet, when she found out that her baby had no heartbeat, she left that appointment with no medical follow-up, and no emotional or mental health support.

Insurance 123
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Industry Voices—Truly inclusive EHR design is within reach

Fierce Healthcare

One in 4 adults in the U.S. | Challenges to inclusive design often stem from viewing disability as a binary status. However, disabilities vary widely in severity and permanency, with symptoms existing on a spectrum.

122
122
article thumbnail

With EU agency's ruling, Moderna tallies a win in vaccine patent war against Pfizer and BioNTech

Fierce Pharma

After Moderna last year suffered a loss in its heated patent fight against Pfizer and BioNTech, the mRNA drugmaker can now celebrate a win. | The win comes after a prior decision from the European Patent Office that invalidated Moderna's other asserted patent.

Vaccines 122
article thumbnail

Sanders issues warning to Novo Nordisk amid GLP-1 drug price investigation

Pharmaceutical Technology

The US Senator took another swipe at the US prices of Novo Nordisk’s blockbuster GLP-1 receptor agonist drugs Ozempic and Wegovy.

116
116
article thumbnail

After Covis' Makena pull, EU regulator flags safety and efficacy problems with similar preterm birth drugs

Fierce Pharma

Following a controversy over Covis’ preterm birth drug Makena in the U.S. last year, the European Medicines Agency (EMA) is cracking down on hydroxyprogesterone caproate therapies across the pond. | A committee of the European Medicines Agency on Friday called for the withdrawal of preterm birth drugs containing 17-hydroxyprogesterone caproate (17-OHPC), citing safety and efficacy concerns.

119
119
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Overcoming challenges with maternal vaccine trials

pharmaphorum

Navigating maternal vaccine trials: addressing safety, efficacy, and preterm birth risks. Insights on vaccines for pregnant women and maternal health.

Vaccines 115
article thumbnail

STAT+: Venture capitalist Bob Kocher on generative AI startups, Change Healthcare cyberattack

STAT

SAN FRANCISCO — Health tech investor Bob Kocher has seen some bad AI-related startup pitches in his time. The worst typically involve AI chatbots masquerading as romantic partners to improve people’s mental health. “They pitch it to me as a mental health improvement model,” Kocher, a partner at venture capital firm Venrock, said.

Hospitals 113
article thumbnail

A greener catalysis: Talking sustainable, scalable chemistry with KCL

pharmaphorum

Explore sustainable catalysis and its potential to transform chemical reactions in drug discovery. Learn how green chemistry plays a pivotal role in shaping the future of catalysis.

115
115
article thumbnail

New Evaluation Standards Needed to Sustain Diabetes Technology Innovation

Drug Topics

Since diabetes technology innovation, combined with strong patient demand, has outpaced current evaluation methods, investigators are calling for new approaches that “keep up with the times.

112
112
article thumbnail

STAT+: To bolster global health, Wellcome Trust’s new CEO thinks Big Tech should get involved

STAT

LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies. But to John-Arne Røttingen, the new head of the Wellcome Trust , one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

article thumbnail

Q&A: Pharmacist Turned Coffee Shop Owner on the Current State of Independent Pharmacy

Drug Topics

Chris Schaffner, owner of Schaffner Pharmacy and Apothecary Coffee in Sedro Woolley, Washington, discussed the state of today’s independent pharmacy market, as well as his own pharmacy operations.

article thumbnail

Lung disease imaging AI from Brainomix gets FDA nod

pharmaphorum

Brainomix gets FDA approval for e-Lung, an AI tool that assists in the diagnosis and assessment of patients with interstitial lung diseases (ILDs) from medical images.

FDA 111
article thumbnail

Check Your Work: Understanding Food Allergies

Drug Topics

Dive in and learn more about the answers to yesterday’s quiz.

112
112
article thumbnail

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

Pharmafile

Amgen has announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) who have had disease progression on or after platinum-based chemotherapy. The post FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer appeared first on Pharmafile.

FDA 111
article thumbnail

Amgen adds BiTE to its cancer range as FDA clears Imdelltra

pharmaphorum

Amgen gets FDA approval for Imdelltra as a treatment for small cell lung cancer, becoming the first DLL3-targeted drug and the company's second BiTE therapy.

FDA 108
article thumbnail

Can food poisoning cause a fever?

The Checkup by Singlecare

Every year, 1 in 6 Americans gets a foodborne illness from eating contaminated food or drinks. One kind of foodborne illness is food poisoning, caused by pathogens like bacteria, viruses, and other microbes. Food poisoning occurs when food is not properly stored, handled, or cooked, causing symptoms like stomach cramps, diarrhea, nausea, and vomiting.

article thumbnail

Obesity drugs could bankrupt US healthcare, says Sanders

pharmaphorum

Bernie Sanders says high prices being charged for new obesity therapies like Novo Nordisk’s Wegovy could end up bankrupting US healthcare systems

105
105
article thumbnail

Pharma Pulse 5/17/24: Apple Watch's Afib App certified by FDA, Learning Telehealth Platforms Benefits Pharmacy Students & more

Pharmaceutical Commerce

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

FDA 104
article thumbnail

J&J reels in bispecific specialist Proteologix in $850m deal

pharmaphorum

Johnson & Johnson has agreed a $850m deal to acquire Proteologix that will give it a pair of early-stage bispecific antibodies for atopic dermatitis and asthma.

104
104
article thumbnail

STAT+: Pharmalittle: We’re reading about an Amgen drug for lung cancer, a Novo plant fire, and more

STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up, but we expect to promenade with the official mascots, take in a moving picture, and hold another listening party, where the rotation will likely include this , this , this , this and this.